Application of Nanoparticles in Drug Delivery and Cancer Therapy

A special issue of Coatings (ISSN 2079-6412).

Deadline for manuscript submissions: closed (10 November 2022) | Viewed by 1610

Special Issue Editor


E-Mail Website
Guest Editor
School of Medicine, Johns Hopkins, Baltimore, MD 21205, USA
Interests: drug delivery; cancer therapy; nanomedicine; polymersomes; targeted therapy

Special Issue Information

Dear Colleagues,

Research in the field of nanomaterials for biomedical applications, particularly for drug delivery in cancer therapeutics, has garnered immense attention in the past few decades due to their versatile functional and structural capabilities. This encompasses a vast field of research, including hard-metal-based nanoparticles, polymeric nanocarriers, protein conjugates, polyplexes, naturally occurring biomaterials and supramolecular systems. Although the pharmacological industry invests immensely in the design and discovery of novel drug molecules, small molecular drugs are often inefficient at targeting many diseases, such as deep-seated low-vasculature tumors, metastasized cancers and various autoimmune diseases. Coupled with a rapid clearance rate, low solubility, drug resistance and high off-target toxicity, these small molecular drugs often present modest benefits for a host of common diseases. In order to improve the therapeutic index of pre-existing drugs and shortening the translation from preclinical validation to clinical approval, a vast area of drug delivery research focuses on the improvement of drug carriers by various alterations. The major challenges currently faced by drug delivery systems include a low payload, transition through the desmoplastic barrier for solid tumors and high hepatic and renal clearance. In order to address these issues, numerous biocompatible nanomaterials have been engineered and have been reported to enhance the stability and pharmacokinetic properties of the active drugs. Ongoing efforts in this field are promising, and may open new horizons for personalized medicine for effective cures for cancer. We invite research articles in the field of nanomaterials used for drug delivery as a potential cure for cancer. This Special Issue will include all aspects of research related to nanoparticles as drug carriers and application-oriented papers, experimental and numerical studies, case studies and reviews.

In particular, the topics of interest include but are not limited to:

  • Nanomaterials;
  • Drug delivery agents;
  • Cancer therapeutics
  • Polymeric particles;
  • Biomaterials for drug delivery;
  • Novel delivery agents;
  • Biocompatible nanomaterials;
  • Targeted therapy.

Dr. Priyanka Ray
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Coatings is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer therapy
  • nanoparticles
  • polymersomes
  • drug delivery
  • nanobiomaterials

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

3 pages, 503 KiB  
Editorial
Nanomaterials as Emerging Therapeutics for the Deadly Coronavirus
by Priyanka Ray
Coatings 2022, 12(8), 1196; https://doi.org/10.3390/coatings12081196 - 16 Aug 2022
Viewed by 1260
Abstract
Since the first reports of a contagious pneumonia such as the disease in China in December 2019, the world has witnessed a situation that very few people have ever seen in their lifetimes [...] Full article
(This article belongs to the Special Issue Application of Nanoparticles in Drug Delivery and Cancer Therapy)
Show Figures

Figure 1

Back to TopTop